SOLICITATION NOTICE
A -- RPS FebriDx Lateral Flow Assay
- Notice Date
- 3/7/2014
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Office of the Chief Procurement Officer, Washington, District of Columbia, 20528, United States
- ZIP Code
- 20528
- Solicitation Number
- JA07314
- Point of Contact
- Danette Williams, Phone: 2022545891, Michael E. Jones, Phone: 202-254-5676
- E-Mail Address
-
danette.williams@hq.dhs.gov, michael..jones@hq.dhs.gov
(danette.williams@hq.dhs.gov, michael..jones@hq.dhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The Department of Homeland Security (DHS), Office of Procurement Operations (OPO), intends to issue a sole source award for the completing and finalizing the development and U.S. Food and Drug Administration (FDA) validation of the RPS FebriDx Lateral Flow Assay (LFA) in support of the DHS Directorate of Science and Technology, Chemical and Biological Defense Division (CBD) to Rapid Pathogen Screening (RPS) Inc., 7727 Delainey Court, Sarasota, FL 34240-8440. The work to be performed will involve the continued development, test, evaluation, and final completion of the current prototype assay and will be used in triage for rapidly screening patients infected (symptomatic), as well as provide comfort to those who may believe they potentially have been exposed (symptomatic and asymptomatic) and who may need post-exposure prophylaxis. The RPS FebriDx LFA will mitigate the consequence of biological incidents through early detection and complement the Government's "detect-to-treat" approach by providing a new capability to DHS and its stakeholders that not only rapidly and accurately diagnoses patients at the point of care, but buys precious time for the delivery of requisite medical countermeasures. Therefore, this requested action to continue support to develop, test, evaluate, and complete the current prototype assay will ensure continuity of the Government's ability to mitigate the consequence of biological incidents. The services to be provided for this proposed sole source action will also offer a solution for the widespread over use of antibiotics (and the resulting increase in antibiotic resistance), and will significantly mitigate the current costs associated with making an accurate diagnosis so that effective treatment can be administered. Note 22: This pre-award synopsis is for informational purposes only. Technical proposals will not be considered, however technical capability statements may be submitted, only if your organization has the technical capabilities necessary to meet the above stated needs. If such documents are submitted, they may be reviewed for consideration to open this requirement up for competition. The determination to open up the requirement to competition is at the sole discretion of the Government. All submissions become the property of the Federal Government, and will not be returned.  
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DHS/OCPO/DHS-OCPO/JA07314/listing.html)
- Place of Performance
- Address: 7727 Delainey Court, Sarasota, Florida, 34240-8440, United States
- Zip Code: 34240-8440
- Zip Code: 34240-8440
- Record
- SN03305052-W 20140309/140307234539-d755146050d27a4a9f7b2f3c9c6acd5a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |